Litchman Manuel MD
Transaction: 04/24/2026
SELL
Change
-19
Price
$0.75
Filing
04/27/2026
Type
SELL
Mustang Bio, Inc.
MBIO • Biotechnology
$0.54
▼ -0.02 (-3.05%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.66M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 2.22Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:22 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.54
Change-3.05%
Shares Out6.73M
Market Cap$3.66M
Enterprise Value$-11.49M
52W Range0.53 - 1.85
Beta2.05
P/E-1.21
P/B0.48
P/FCF-0.81
EV/EBITDA3.41
EV/FCF2.55
Price$0.54
Change-3.05%
Shares Out6.73M
Market Cap$3.66M
Enterprise Value$-11.49M
52W Range0.53 - 1.85
Beta2.05
P/E-1.21
P/B0.48
P/FCF-0.81
EV/EBITDA3.41
EV/FCF2.55
Earnings Yield-82.97%
FCF Yield-123.41%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio2.22
Quick Ratio2.22
Volume9.39K
Avg Volume103.11K
EPS Surprise139.86
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 2.22Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
100/100
Bullish
Bullish
7
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Fortress Biotech, Inc.
Transaction: 01/02/2026
BUY
Change
+278,385
Price
Not reported
Filing
01/05/2026
Type
BUY
Jin David
Transaction: 12/30/2025
BUY
Change
+247
Price
$0.96
Filing
12/30/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Litchman Manuel MD | SELL | -19 | $0.75 | 04/24/2026 | 04/27/2026 |
| Fortress Biotech, Inc. | BUY | +278,385 | Not reported | 01/02/2026 | 01/05/2026 |
| Jin David | BUY | +247 | $0.96 | 12/30/2025 | 12/30/2025 |
| Chill Adam J. | SELL | -4 | $0.95 | 12/30/2025 | 12/30/2025 |
| Herskowitz Neil | SELL | -247 | $0.96 | 12/30/2025 | 12/30/2025 |
| Fortress Biotech, Inc. | BUY | +59,334 | Not reported | 09/29/2025 | 10/01/2025 |
| Litchman Manuel MD | SELL | -27 | $1.24 | 04/24/2025 | 04/28/2025 |
| Fortress Biotech, Inc. | BUY | +67,806 | Not reported | 03/31/2025 | 04/02/2025 |
| Fortress Biotech, Inc. | OTHER | 0 | Not reported | 12/31/2024 | 01/03/2025 |
| Jin David | OTHER | 0 | Not reported | 10/23/2024 | 10/29/2024 |
| Fortress Biotech, Inc. | BUY | +575,191 | Not reported | 06/27/2024 | 06/28/2024 |
| Litchman Manuel MD | SELL | -1,396 | $0.35 | 05/31/2024 | 06/04/2024 |
| Litchman Manuel MD | SELL | -1,572 | $4.21 | 04/24/2023 | 06/04/2024 |
| Litchman Manuel MD | SELL | -1,248 | $12.15 | 04/24/2022 | 06/04/2024 |
| MURPHY JAMES B | OTHER | 0 | Not reported | 01/19/2024 | 02/12/2024 |
| Fortress Biotech, Inc. | BUY | +419,092 | Not reported | 01/02/2024 | 01/03/2024 |
| Carney Peter | SELL | 0 | Not reported | 12/11/2023 | 12/19/2023 |
| Herskowitz Neil | BUY | +7,246 | Not reported | 07/05/2023 | 07/07/2023 |
| WEISS MICHAEL S | BUY | +7,246 | Not reported | 07/05/2023 | 07/07/2023 |
| ROSENWALD LINDSAY A MD | BUY | +7,246 | Not reported | 07/05/2023 | 07/07/2023 |